What is the ticker symbol for Summit Therapeutics?

Summit Therapeutics trades under the ticker SMMT on NASDAQ.

What sector does Summit Therapeutics operate in?

Summit Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SMMT in a portfolio?

PortView shows SMMT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Summit Therapeutics (SMMT) Stock Analysis

NASDAQHealthcareBiotechnology

$14.15-0.05%

1-year price historyRange $12.43 – $26.38

52-week range$14.15

$12.07$29.23

What Summit Therapeutics does

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

$11.29B

P/E (TTM)

-12.64

EPS (TTM)

$-1.12

Beta

-1.24

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$14.08

200-day avg

$16.43

52-week high

$29.23

52-week low

$12.07

CEO

Robert W. Duggan

ETFs linked to SMMT

Broad-market and Healthcare sector ETFs an investor holding Summit Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SMMT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SMMT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Summit Therapeutics?: Summit Therapeutics trades under the ticker SMMT on NASDAQ.
Which exchange is SMMT listed on?: SMMT is listed on NASDAQ.
What sector does Summit Therapeutics operate in?: Summit Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SMMT in a portfolio?: PortView shows SMMT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.